Algorithm for monitoring patients with axial spondyloarthritis depending on the activity of the disease
Axial spondyloarthritis (axSpA) is actively treated with biologic disease-modifying antirheumatic drugs, but their efficacy decreases over time, leading to the development of exacerbation, the onset of severe and chronic pain, progression of structural changes and deterioration of quality of life, a...
Saved in:
| Main Authors: | A. V. Datsina, Sh. F. Erdes |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2025-02-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1705 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical features of patients with ankylosing spondylitis with inefficacy of two or more biological disease modifying antirheumatic drugs
by: Sh. F. Erdes, et al.
Published: (2023-07-01) -
Recent advances and prospects of axial spondyloarthritis / ankylosing spondylitis treatment
by: Sh. F. Erdes
Published: (2021-04-01) -
Difficult-to-treat rheumatoid arthritis in the clinical practice of a rheumatological hospital. First look
by: A. V. Gordeev, et al.
Published: (2022-05-01) -
Medical and social significance and calculation of the economic burden of axial spondyloarthritis in the Russian Federation
by: A. M. Lila, et al.
Published: (2022-02-01) -
Personalized dose reduction strategies for biologic disease-modifying antirheumatic drugs for treating axial spondyloarthritis: a clinical and economic evaluation with predictive modeling
by: Bui Hai Binh, et al.
Published: (2025-05-01)